• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性进展型与复发缓解型多发性硬化症的脑和脊髓磁共振成像病变

Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.

作者信息

Dastagir Akram, Healy Brian C, Chua Alicia S, Chitnis Tanuja, Weiner Howard L, Bakshi Rohit, Tauhid Shahamat

机构信息

Departments of Neurology and Brigham and Women's Hospital, Laboratory for Neuroimaging Research, Partners MS Center, Harvard Medical School, USA.

Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.

出版信息

eNeurologicalSci. 2018 Jul 4;12:42-46. doi: 10.1016/j.ensci.2018.07.002. eCollection 2018 Sep.

DOI:10.1016/j.ensci.2018.07.002
PMID:30229136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6141305/
Abstract

BACKGROUND

Primary progressive (PP) multiple sclerosis (MS) is considered a clinically distinct entity from the spectrum of relapsing-remitting (RR) forms of the disease.

OBJECTIVE

To compare the presence of brain and spinal cord lesions between PP and RR subjects.

METHODS

We studied people with PPMS [ = 40, 17 (42.5%) men, age 50.7 ± 7.7 years, disease duration 10.1 ± 7.4 years, Expanded Disability Status Scale (EDSS) score 4.6 ± 2.1] and RRMS [ = 40, 12 (30%) men, age 47.9 ± 4.2, disease duration 13.7 ± 5.9, EDSS 1.7 ± 1.3]. MRI of the brain and full spinal cord at 1.5T was analyzed to define patients having: 1. brain only, 2. spinal cord only, or 3. brain and spinal cord MS lesions.

RESULTS

Lesions in the brain only were less common in PP ( = 1, 2.5% of people) than RR ( = 10, 25%) (Fisher's exact  = 0.007). Lesions in the spinal cord only (PP:  = 6, 15%, RR:  = 3, 7.5%,  = 0.481) or brain plus spinal cord (PP:  = 33, 83%, RR:  = 27, 68%,  = 0.196) were similar between groups. PP had higher EDSS and timed 25-ft walk (Wilcoxon tests, both  < 0.001), higher age (-test  = 0.049), lower disease duration (-test,  = 0.02), and a similar sex ratio (Fisher's exact  = 0.352) vs. RR.

CONCLUSIONS

We report a topographic difference in MRI lesion involvement between PPMS and RRMS. Lesions restricted to the brain are more common in RRMS. These findings provide support to the notion that PP may have features distinctive from the RR spectrum of the disease. Longitudinal comparisons and quantitative MRI analysis would be necessary to confirm and extend these results.

摘要

背景

原发性进展型(PP)多发性硬化(MS)被认为是一种在临床上与复发缓解型(RR)疾病谱不同的实体。

目的

比较PP和RR受试者脑和脊髓病变的情况。

方法

我们研究了PPMS患者[=40例,17例(42.5%)男性,年龄50.7±7.7岁,病程10.1±7.4年,扩展残疾状态量表(EDSS)评分4.6±2.1]和RRMS患者[=40例,12例(30%)男性,年龄47.9±4.2岁,病程13.7±5.9年,EDSS 1.7±1.3]。对1.5T的脑部和全脊髓MRI进行分析,以确定患者有:1.仅脑部病变;2.仅脊髓病变;或3.脑部和脊髓MS病变。

结果

仅脑部病变在PP患者中(=1例,占患者的2.5%)比RR患者中(=10例,占25%)少见(Fisher精确检验=0.007)。仅脊髓病变(PP:=6例,占15%,RR:=3例,占7.5%,=0.481)或脑部加脊髓病变(PP:=33例,占83%,RR:=27例,占68%,=0.196)在两组之间相似。与RR相比,PP的EDSS和25英尺步行时间更长(Wilcoxon检验,均<0.001),年龄更大(t检验=0.049),病程更短(t检验,=0.02),性别比例相似(Fisher精确检验=0.352)。

结论

我们报告了PPMS和RRMS在MRI病变累及部位上的差异。局限于脑部的病变在RRMS中更常见。这些发现支持了PP可能具有与RR疾病谱不同特征的观点。需要进行纵向比较和定量MRI分析来证实和扩展这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0d/6141305/e36854e1baf5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0d/6141305/563612f9892a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0d/6141305/e36854e1baf5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0d/6141305/563612f9892a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0d/6141305/e36854e1baf5/gr2.jpg

相似文献

1
Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.原发性进展型与复发缓解型多发性硬化症的脑和脊髓磁共振成像病变
eNeurologicalSci. 2018 Jul 4;12:42-46. doi: 10.1016/j.ensci.2018.07.002. eCollection 2018 Sep.
2
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.脑和脊髓髓鞘水成像:一种进展性多发性硬化症生物标志物。
Neuroimage Clin. 2015 Oct 3;9:574-80. doi: 10.1016/j.nicl.2015.10.002. eCollection 2015.
3
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.局灶性颈脊髓病变累及灰质与进展型多发性硬化症相关。
Mult Scler. 2016 Jun;22(7):910-20. doi: 10.1177/1352458515604905. Epub 2015 Oct 2.
4
7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.7T 成像显示多发性硬化症的脊髓病变分布呈梯度变化。
Brain. 2020 Oct 1;143(10):2973-2987. doi: 10.1093/brain/awaa249.
5
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.多参数 MRI 评估在多发性硬化症中对颈髓损伤的临床相关性。
Radiology. 2020 Sep;296(3):605-615. doi: 10.1148/radiol.2020200430. Epub 2020 Jun 23.
6
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.多发性硬化症中的脑和脊髓异常。MRI参数、临床亚型与症状之间的相关性。
Brain. 1998 Apr;121 ( Pt 4):687-97. doi: 10.1093/brain/121.4.687.
7
Cervical cord lesion load is associated with disability independently from atrophy in MS.颈髓损伤负荷与 MS 患者的残疾独立相关,与萎缩无关。
Neurology. 2015 Jan 27;84(4):367-73. doi: 10.1212/WNL.0000000000001186. Epub 2014 Dec 24.
8
Primary and transitional progressive MS: a clinical and MRI cross-sectional study.
Neurology. 1999 Mar 10;52(4):839-45. doi: 10.1212/wnl.52.4.839.
9
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.脊髓灰质异常与多发性硬化症的继发性进展和身体残疾有关。
J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):608-14. doi: 10.1136/jnnp-2014-308241. Epub 2014 Aug 5.
10
Mitoxantrone: a review of its use in multiple sclerosis.米托蒽醌:其在多发性硬化症中的应用综述
CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010.

引用本文的文献

1
Alterations in neutrophil mRNA profiles in multiple sclerosis and identification of candidate genes for further investigation.多发性硬化症中性粒细胞mRNA谱的改变及进一步研究候选基因的鉴定。
Front Neurol. 2025 Feb 17;16:1548196. doi: 10.3389/fneur.2025.1548196. eCollection 2025.
2
Disability independent of cerebral white matter demyelination in progressive multiple sclerosis.进展性多发性硬化症中与脑白质脱髓鞘无关的残疾。
Acta Neuropathol. 2024 Aug 31;148(1):34. doi: 10.1007/s00401-024-02796-w.
3
Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes.

本文引用的文献

1
Ocrelizumab: a new milestone in multiple sclerosis therapy.奥瑞珠单抗:多发性硬化症治疗的一个新里程碑。
Ther Adv Neurol Disord. 2018 May 10;11:1756286418773025. doi: 10.1177/1756286418773025. eCollection 2018.
2
Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.轻度复发缓解型与原发性进展型多发性硬化症的全球转录组谱分析。
Eur J Neurol. 2018 Apr;25(4):651-658. doi: 10.1111/ene.13565. Epub 2018 Feb 13.
3
Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.
外周血免疫状态与鞘内炎症标志物之间的关联可区分多发性硬化症的临床表型。
Acta Neurol Belg. 2024 Dec;124(6):1935-1944. doi: 10.1007/s13760-024-02597-8. Epub 2024 Aug 3.
4
Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review.维生素 D 补充治疗多发性硬化症患者的临床和影像学结局:系统评价。
Nutrients. 2023 Apr 18;15(8):1945. doi: 10.3390/nu15081945.
5
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4.血清神经丝轻链和神经胶质纤维酸性蛋白作为原发性进行性多发性硬化症和遗传性痉挛性截瘫 4 型的生物标志物。
Int J Mol Sci. 2022 Nov 3;23(21):13466. doi: 10.3390/ijms232113466.
6
Peripartum disease activity in moderately and severely disabled women with multiple sclerosis.患有多发性硬化症的中度和重度残疾女性的围产期疾病活动情况。
Mult Scler J Exp Transl Clin. 2022 Jun 15;8(2):20552173221104918. doi: 10.1177/20552173221104918. eCollection 2022 Apr-Jun.
7
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.针对癌症和自身免疫性疾病中 CD95L/CD95 信号的治疗方法。
Cell Death Dis. 2022 Mar 17;13(3):248. doi: 10.1038/s41419-022-04688-x.
8
Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment.综述血脑屏障破坏在多发性硬化症发病机制和治疗中的意义。
Int J Mol Sci. 2021 Aug 4;22(16):8370. doi: 10.3390/ijms22168370.
9
3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.3T 相位敏感反转恢复磁共振成像的快速三维灰质采集:在多发性硬化症患者中检测脊髓病变的应用。
PLoS One. 2021 Apr 22;16(4):e0247813. doi: 10.1371/journal.pone.0247813. eCollection 2021.
10
Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS).中性粒细胞:多发性硬化症(MS)发病机制中被低估的角色。
Int J Mol Sci. 2020 Jun 26;21(12):4558. doi: 10.3390/ijms21124558.
脊髓作为脑磁共振成像的辅助手段在明确多发性硬化症“无疾病活动证据”中的应用
Int J MS Care. 2017 May-Jun;19(3):158-164. doi: 10.7224/1537-2073.2016-068.
4
Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis.多发性硬化症患者临床与磁共振成像分离特征分析
J Neuroimaging. 2017 Sep;27(5):481-485. doi: 10.1111/jon.12433. Epub 2017 Mar 6.
5
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.进行性多发性硬化症:从发病机制到治疗。
Brain. 2017 Mar 1;140(3):527-546. doi: 10.1093/brain/aww258.
6
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.原发性进行性多发性硬化症的口服芬戈莫德(INFORMS):一项 3 期、随机、双盲、安慰剂对照试验。
Lancet. 2016 Mar 12;387(10023):1075-1084. doi: 10.1016/S0140-6736(15)01314-8. Epub 2016 Jan 28.
7
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.7T下多发性硬化症患者颈脊髓的磁共振成像
Mult Scler. 2016 Mar;22(3):320-8. doi: 10.1177/1352458515591070. Epub 2015 Jul 24.
8
Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.多发性硬化症的脊髓 MRI——诊断、预后和临床价值。
Nat Rev Neurol. 2015 Jun;11(6):327-38. doi: 10.1038/nrneurol.2015.80. Epub 2015 May 26.
9
Progression rates and sample size estimates for PPMS based on the CLIMB study population.基于CLIMB研究人群的进展性多发性硬化症的进展率和样本量估计。
Mult Scler. 2015 Feb;21(2):180-8. doi: 10.1177/1352458514541976. Epub 2014 Jul 28.
10
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.颈椎脊髓容积损失与多发性硬化的临床残疾进展有关。
J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):410-8. doi: 10.1136/jnnp-2014-308021. Epub 2014 Jun 27.